NOVEL
  • EVIE has broken new ground and is the first patented, approved slow release insemination device available for sale in the world. Reproductive Sciences (RSL) has an exclusivity agreement with its subsidiary in Israel, Fertiligent, to sell EVIE worldwide.
  • Research and trials show EVIE more than doubles the patients chances of success, compared with standard IUI, in the under 35 age group.
  • EVIE is less than half the cost per pregnancy when compared to IUI. 

 

 

  • EVIE is convenient and the patient can leave the clinic shortly after the device has been fitted. EVIE can be removed by the patient after the four hour duration.
  • A clinical study in the US has shown EVIE is as comfortable as regular IUI for the patient.
  • In addition to targeting the IUI market, in time and with appropriate clinical data, EVIE will be able to capture a significant share of the IVF patient market segment.
  • EVIE is fully developed and patented (US patent number 8088105) and US marketing approval (FDA 510(k)).

FIND YOUR LOCAL
CLINIC

Click Here

DOWNLOAD
LITERATURE

PatientsClinicians

Image result for video camera icon

WATCH
THE VIDEO

Click Here